HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomasz Świtaj Selected Research

Tomasz Świtaj Research Topics

Disease

9Melanoma (Melanoma, Malignant)
05/2024 - 01/2015
5Sarcoma (Soft Tissue Sarcoma)
12/2021 - 08/2014
3Disease Progression
05/2024 - 01/2015
3Perivascular Epithelioid Cell Neoplasms
01/2023 - 08/2014
2Neoplasms (Cancer)
08/2022 - 08/2014
2Neurofibrosarcoma (MPNST)
12/2020 - 09/2020
2Alveolar Soft Part Sarcoma
05/2017 - 08/2014
1Stomach Neoplasms (Stomach Cancer)
12/2021
1Ewing Sarcoma (Sarcoma, Ewing)
08/2021
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021
1Synovial Sarcoma (Synovioma)
09/2020
1Dermatofibrosarcoma
08/2014
1Giant Cell Tumor of Bone
08/2014
1Clear Cell Sarcoma
08/2014

Drug/Important Bio-Agent (IBA)

2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2023 - 10/2018
1pembrolizumabIBA
09/2023
1NivolumabIBA
09/2023
1trametinibIBA
09/2023
1dabrafenibIBA
09/2023
1MTOR InhibitorsIBA
01/2023
1tributyl phosphate (TBP)IBA
08/2022
1Circulating Tumor DNAIBA
02/2022
1Sirolimus (Rapamycin)FDA Link
08/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1Immune Checkpoint InhibitorsIBA
10/2019
1Sunitinib (Sutent)FDA Link
05/2017
1VemurafenibIBA
01/2015

Therapy/Procedure

12Therapeutics
05/2024 - 08/2014
5Drug Therapy (Chemotherapy)
01/2023 - 08/2014
4Immunotherapy
05/2024 - 10/2019
3Radiotherapy
08/2022 - 06/2021
1Neoadjuvant Therapy
12/2021
1Adjuvant Radiotherapy
06/2021